Literature DB >> 15159063

cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.

Berhane Ghebrehiwet1, Ellinor I B Peerschke.   

Abstract

The first component of complement, C1, is a multi-molecular complex comprising of C1q and the Ca(2+)-dependent tetramer C1r(2)-C1s(2). The traditional role of C1q within the complex is that of recognition signal-a signal, which is instantly converted into a highly specific intramolecular proteolytic activation of the C1r(2)-C1s(2) tetramer thereby triggering activation of the classical pathway. Another important function of C1q is its ability to bind to a wide range of cell types resulting in the induction of cell-specific biological responses. These cells include polymorphonuclear leukocytes, monocytes, lymphocytes, dendritic cells, endothelial cells and platelets. Interaction of C1q with endothelial cells and platelets, for example, leads to cellular activation followed by release of biological mediators and/or expression of adhesion molecules, all of which contribute, directly or indirectly to the inflammatory process. These specific responses are mediated by the interaction of C1q with C1q binding proteins or receptors on the cell surface. To date, four types of putative C1q binding cell surface expressed proteins/receptors have been described. These include cC1q-R/CR, or calreticulin (CR), a 60 kDa protein, which is also known as collectin receptor; gC1q-R/p33, a 33 kDa homotrimeric protein; C1q-Rp (CD93), a 120 kDa, O-sialoglycoprotein; and CR1 (CD35), the receptor for C3b. Although the specific role of each of these molecules in a given C1q-mediated cellular response is yet to be worked out, all of them may, in one form or another, participate in the inflammatory processes associated with vascular or atherosclerotic lesions, autoimmune diseases, or infections. The main focus of our laboratory for the past 20 years has been to elucidate the structure and function of cC1q-R/CR and gC1q-R/p33, both of which have been isolated and characterized on the basis of their ability to bind C1q. The purpose of this article is therefore to provide an up to date overview of these two proteins with particular emphasis on their unique structural and functional features, their multi-faceted nature and most importantly their role in infection and inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159063     DOI: 10.1016/j.molimm.2004.03.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  51 in total

1.  Hepatic Endosome Protein Profiling in Apolipoprotein E Deficient Mice Expressing Apolipoprotein B48 but not B100.

Authors:  Anshu Chen; Zhongmao Guo; Lichun Zhou; Hong Yang
Journal:  J Bioanal Biomed       Date:  2010-09-23

Review 2.  Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

Authors:  Robert P Schleimer
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Use of OmpU porins for attachment and invasion of Crassostrea gigas immune cells by the oyster pathogen Vibrio splendidus.

Authors:  Marylise Duperthuy; Paulina Schmitt; Edwin Garzón; Audrey Caro; Rafael D Rosa; Frédérique Le Roux; Nicole Lautrédou-Audouy; Patrice Got; Bernard Romestand; Julien de Lorgeril; Sylvie Kieffer-Jaquinod; Evelyne Bachère; Delphine Destoumieux-Garzón
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.

Authors:  Glenda Trujillo; Jianhua Zhang; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard R Kew
Journal:  Mol Immunol       Date:  2011-10-19       Impact factor: 4.407

6.  Classical pathway complement activation on human endothelial cells.

Authors:  Wei Yin; Berhane Ghebrehiwet; Babette Weksler; Ellinor I Peerschke
Journal:  Mol Immunol       Date:  2006-12-14       Impact factor: 4.407

7.  C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.

Authors:  Kun Kim; Min-Jeong Kim; Kyung-Hee Kim; Sun-A Ahn; Jong Heon Kim; Jae Youl Cho; Seung-Gu Yeo
Journal:  Exp Ther Med       Date:  2017-03-21       Impact factor: 2.447

8.  Proteomic mapping of stimulus-specific signaling pathways involved in THP-1 cells exposed to Porphyromonas gingivalis or its purified components.

Authors:  Julian A Saba; Mark E McComb; Donna L Potts; Catherine E Costello; Salomon Amar
Journal:  J Proteome Res       Date:  2007-05-04       Impact factor: 4.466

9.  Surfactant protein A influences reepithelialization in an alveolocapillary model system.

Authors:  Coen H M P Willems; Luc J I Zimmermann; Renate M R Langen; Maria J A van den Bosch; Nico Kloosterboer; Boris W Kramer; J Freek van Iwaarden
Journal:  Lung       Date:  2012-10-13       Impact factor: 2.584

10.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.